Supporting healthy ageing: The critical role of Nurses in protecting older adults against RSV-LRTD

Join us for an exclusive educational webinar focused on the burden of RSV disease in older adults. This session is specially designed to support the implementation of AREXVY, the only adjuvanted RSV vaccine for older adults,*1 by our dedicated Australian Nurses.

*AREXVY is indicated for active immunisation of individuals 60 years and older for the prevention of lower respiratory tract disease caused by respiratory syncytial virus (RSV).1